=========================================
=========================================
CHARACTERISTICS
=========================================
=========================================
Baseline
|
|
Overall
|
|
n
|
147
|
|
Edad (mean (SD))
|
35.03 (7.36)
|
|
Edad.fu (mean (SD))
|
43.01 (8.11)
|
|
CxAd.1 (%)
|
|
|
AS
|
84 (57.1)
|
|
CBDCAx1
|
30 (20.4)
|
|
CBDCAx2
|
33 (22.4)
|
|
Mayor4.1 = Si (%)
|
73 (50.3)
|
|
RETE.1 = Si (%)
|
45 (30.8)
|
|
Risk.Factor1 (%)
|
|
|
0
|
59 (40.1)
|
|
1
|
58 (39.5)
|
|
2
|
30 (20.4)
|
|
fu.m2 (%)
|
|
|
Fu 0-5
|
41 (27.9)
|
|
Fu 5-10
|
61 (41.5)
|
|
Fu >10
|
45 (30.6)
|
|
Nro.Platinos2 (%)
|
|
|
0
|
65 (46.8)
|
|
1
|
28 (20.1)
|
|
≥2
|
46 (33.1)
|
|
Recaida.1 = Si (%)
|
17 (11.7)
|
|
TesteContralateral.1 = Si (%)
|
4 ( 3.1)
|
|
Testosterone.1 = Si (%)
|
60 (47.6)
|
|
Hipogonadismo.fu.woTC.1 = Si (%)
|
6 ( 4.8)
|
|
Hipogonadismo.fu.wTC.1 = Si (%)
|
9 ( 7.1)
|
|
HTA.fu.1 = Si (%)
|
7 ( 5.6)
|
|
DLP.fu.1 = Si (%)
|
28 (22.0)
|
=========================================
=========================================
TIME TO DISEASE
=========================================
=========================================
Time to Hypogonadism censoring 2nd TC
Time to Hypogonadism without censoring 2nd TC
Time to HTA
Time to DLP
=========================================
=========================================
RECURRENCE FREE SURVIVAL
=========================================
=========================================
Recurrence-Free Sruvival
